Recent APS Webinar Recordings

As an APS member, you will always have access to recordings of the Webinars we hold. Click on the thumbnails below to view.

Cell & Gene Therapy: From concept to clinical use

From May 12th 2021.

Drug Design and Developement

ARPAN DESAI, Astra Zeneca- Design and Delivery methods for gene therapies

CHRISTINE DUFES, Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS) Glasgow-Development of gene-based nanomedicines for cancer therapy

CHRIS VAN DER WALLE, GlaxoSmithKline- Formulation considerations for T-cell therapies

View Video Recording

From May 19th 2021.

Manufacture for advanced medicinal and therapeutic products

JULIE KERBY-Managing Director Industrialisation, Cell and Gene Therapy Catapult

View Video Recording

From May 26th 2021.

CMC Regulations and clinical Use

ALICE MASON-The Royal Marsden NHS Foundation Trust, London, UK & JOANNE BROADHEAD-Freeline Therapeutics Limited

View Video Recording

Nanomedicines: “Crossing Biological Barriers with Nanomedicines”

From April 29th 2021.

“Phenotypic nanomedicines: integrating personalised medicine into drug delivery”

Prof Giuseppe Battaglia-ICREA Research Professor, Chair of Molecular Bionics,Institute for Bioengineering of Catalonia, Barcelona Institute of Science and Technology. Department of Chemistry, Institute for the Physics of Living Systems, University College London

View Video Recording

From June 24th 2021.

Webinar & Fireside chat


Nanomedicines to enable innovative medicines- Dr Marianne Ashford-Astra Zeneca

View Video Recording

From July 29th 2021.

Webinar


Taking a nanoparticle medical product into the global market- Dr Eric Mayes- Endomag Ltd

View Video Recording

Developing Clinically Relevant Dissolution Specifications
(CRDS) for Oral Drug Products

From January 19th 2021.

“Clinically Relevant Dissolution Specifications – Why, What, and How ?”

Dr Paul Dickinson – SEDA Pharmaceutical Development Services and Dr Andreas Abend – MSD

View Video Recording

From March 2nd 2021.

“Clinically Relevant Dissolution Specifications – Introduction to PBPK/PBBM. The How and the Why.

Andrea Moir-Astra Zeneca & Susan Cole MHRA

View Video Recording

From April 20th 2021.

How to develop CRDS including case studies from Industry

Diansong Zhou, Xavier Pepin (AZ),Christophe Tistaert (Janssen)

View Video Recording

From May 18th 2021.

Overview of global regulatory trends within CRDS including progress, challenges and emerging opportunities

Om Anand- FDA & Aris Dokoumetzidis-University of Athens (Greece)

View Video Recording

From June 15th 2021.

Future developments with PBBM/PBPK software packages

Maxime Le Merdy (Simulations Plus) & David Turner (Certara)

View Video Recording

From June 29th 2021.

Emerging opportunities within PBPK/PBBM modelling to support CRDS including new research areas


Speakers-Jenny Dressman, Fraunhofer Institute of Translational Medicine and Pharmacology & Brendan Griffin University College Cork & Adam Darwich, KTH Royal Institute of Technology

View Video Recording

Webinar Autumn 2020 – APS Age Related Medicines Focus Group

From September 30th 2020.

Ameliorating the gut microbiome for longevity and healthy ageing ​ –

Laura McCoubrey​-UCL School of Pharmacy

The Gut Microbiome and drug interactions: Biopharmaceutical and oral bioavailability considerations –

Dr Brendan Griffin-University College Cork

View Video Recording

From October 21st 2020.

The Ageing Gut: Biopharmaceutical Considerations

Francesca Gavins-UCL School of Pharmacy

Mind the Gap Between the Design and Administration of Oral Medicines for Older People

Neel Desai-UCL School of Pharmacy

View video recording

From November 5th 2020.

Including the Elderly in Clinical Trials – a Regulatory Viewpoint-

David Jones-MHRA

View video recording

From November 19th 2020.

Drug Development in Age-Related Medicines and Challenges in Low and Middle Income Countries (LMICs): An academic and pharmaceutical industry perspective

Professor Trevor Jones-Founder member of Medicines for Malaria Venture (MMV) -Director Arix Bioscience plc,Former R&D Director, Wellcome Foundation

Dr Bahijja Raimi-Abraham-Lecturer in Pharmaceutics King’s College London Fight the Fakes Founder and Academic Lead.

View video recording